| Self-Directed Positive Psychology Intervention for Newly Diagnosed Multiple Sclerosis (NCT06891937) | Brigham and Women's Hospital | 2022-07-20 |
| Prediction of Non-motor Symptoms in Fully Ambulatory MS Patients Using Vocal Biomarkers (NCT05561621) | Insel Gruppe AG, University Hospital Bern | 2022-07-15 |
| Hybrid Rehabilitation Approach Through Group Exercise and Telerehabilitation in Patients With Multiple Sclerosis (NCT05469568) | Brno University Hospital | 2022-07-15 |
| A Study on the Safety of Ozanimod Exposure in Pregnant Women and Their Offspring (NCT05170126) | Bristol-Myers Squibb | 2022-07-15 |
| ADAs to Alemtuzumab (NCT06310343) | Queen Mary University of London | 2022-07-12 |
| Efficacy of COVID-19 Vaccination in Patients With Multiple Sclerosis Treated With Immune Modulating Medication (NCT04796584) | Providence Health & Services | 2022-07-11 |
| Study of Empathy in MS (NCT05332951) | Assistance Publique - Hôpitaux de Paris | 2022-07-04 |
| Psychometric Evaluation in Patients With Brain Damage During Neuroinflammation (NCT05450237) | Neuromed IRCCS | 2022-07-01 |
| Preventing the Progression of Multiple Sclerosis: Early Rehabilitative Treatment and Multimodal Assessment - Part A (NCT06219291) | Fondazione Don Carlo Gnocchi ETS | 2022-07-01 |
| Nature of the Link Between Executive Functions and Theory of Mind in Multiple Sclerosis (NCT04806217) | Lille Catholic University | 2022-07-01 |
| Immunoglobulin Deficiency a Treatable Cause of Fatigue in Patients With Multiple Sclerosis (MS)? (NCT05357781) | Insel Gruppe AG, University Hospital Bern | 2022-07-01 |
| Validity and Reliability of Turkish Version Leg Activity Measure (NCT05182411) | Kahramanmaras Sutcu Imam University | 2022-06-30 |
| Immersive Virtual Reality for Upper Limb Rehabilitation in Multiple Sclerosis (NCT05320237) | Glasgow Caledonian University | 2022-06-26 |
| An Online Lifestyle Modification Course for People With Multiple Sclerosis (NCT05374473) | University of Melbourne | 2022-06-24 |
| Identifying and Characterizing Preclinical MS (NCT05787795) | Yale University | 2022-06-21 |
| Safety of Exposure to Natalizumab During Pregnancy (NCT05209815) | University Hospital, Bordeaux | 2022-06-20 |
| Exercise Effects in Multiple Sclerosis (NCT05496881) | University of Regina | 2022-06-15 |
| Visual Processing Speed and Objective Analysis of Ocular Movements in Multiple Sclerosis (NCT05706220) | Instituto Universitario de Oftalmobiología Aplicada (Institute of Applied Ophthalmobiology) - IOBA | 2022-06-13 |
| The Effect of an Interactive Web-based Program in the Management of Multiple Sclerosis (NCT05393765) | Selcuk University | 2022-06-13 |
| RELAXaHEAD for Headache Patients (Phase II) (NCT05466682) | NYU Langone Health | 2022-06-09 |
| PET Imaging of Cyclooxygenase in Multiple Sclerosis (NCT05062083) | National Institute of Mental Health (NIMH) | 2022-06-07 |
| Pharmacogenetics of Liver Toxicity in Patients With Multiple Sclerosis Treated With Fingolimod (NCT05516303) | University Hospital, Caen | 2022-06-07 |
| Fatigue and Sleep Quality in Multiple Sclerosis Patients (NCT05456464) | Istanbul Sabahattin Zaim University | 2022-06-01 |
| EXOPULSE Mollii Suit, Motor Function & Multiple Sclerosis (NCT06702137) | Institut De La Colonne Vertebrale Et Des Neurosciences | 2022-06-01 |
| Feasibility of Neuromodulation With Connectivity-Guided iTBS for Cognitive Impairment in MS (NCT04931953) | University of Nottingham | 2022-06-01 |
| Gait Analysis in Multiple Sclerosis Patients (NCT05299151) | Istanbul Kültür University | 2022-06-01 |
| The Effect of Obesity on Contralateral Suppression in Patients With Multiple Sclerosis (NCT07136311) | Ondokuz Mayıs University | 2022-06-01 |
| Novel Imaging Markers in SPMS (NCT05357833) | University of Utah | 2022-06-01 |
| Effects of Motor Imagery and Action Observation in People With Multiple Sclerosis (NCT05377476) | Hacettepe University | 2022-06-01 |
| COVID-19 on Disease Activity in Radiologically Isolated Syndrome Cohort (NCT05387395) | Centre Hospitalier Universitaire de Nice | 2022-05-31 |
| Aerobic Exercise in Persons With Multiple Sclerosis With Restless Legs Syndrome (NCT05402956) | Dokuz Eylul University | 2022-05-30 |
| Function Magnetic Resonance Imaging to Assess Two Therapeutic Strategies in Multiple Sclerosis (NeuroRehEM). (NCT05270239) | Universitat Jaume I | 2022-05-27 |
| Remote Exercise Effects on Cognitive Processing Speed in Multiple Sclerosis: A Pilot Trial (NCT05344040) | Kessler Foundation | 2022-05-25 |
| Spinal COrd NeuromodulaTor by SpIneX and ScoNE to Treat NeurogeniC BladdEr - SCONE "CONTINENCE" Clinical Study (NCT05301335) | SpineX Inc. | 2022-05-25 |
| Optimizing Detection and Prediction of Changes in Cognitive Function in Multiple Sclerosis (MS) (NCT05252195) | University of Michigan | 2022-05-24 |
| A Study to Assess COVID-19 Vaccination Immune Response in Multiple Sclerosis Patients Treated With Ofatumumab (NCT06460324) | Novartis Pharmaceuticals | 2022-05-20 |
| Validity and Reliability of the Modified Four Square Step Test in Multiple Sclerosis Patients (NCT05182398) | Kahramanmaras Sutcu Imam University | 2022-05-15 |
| A Study of LP-168 in Healthy Volunteers (NCT05432713) | Guangzhou Lupeng Pharmaceutical Company LTD. | 2022-05-14 |
| Clinical and Instrumental Treatment's Predictors in Subjects With Neurological Diseases Using G-EO Robotic System (NCT05493514) | Fondazione Don Carlo Gnocchi ETS | 2022-05-13 |
| Effects of a CT-100 DiNaMo Component on Cognitive Functioning and Mood Symptoms (NCT05438147) | Click Therapeutics, Inc. | 2022-05-13 |
| Kesimpta® (Ofatumumab) in Swiss Multiple Sclerosis Patients - an Observational Study (NCT05285904) | Novartis Pharmaceuticals | 2022-05-12 |
| Improving the Effect of Multiple Sclerosis Drugs by Chronobiology (NCT06385197) | Hadassah Medical Organization | 2022-05-08 |
| Longitudinal Cortical Demyelination in Multiple Sclerosis and Related Disorders (NCT05982925) | Icahn School of Medicine at Mount Sinai | 2022-05-06 |
| The Feasibility of Frame Running as an Exercise Option for People With Multiple Sclerosis (NCT05234879) | Queen Margaret University | 2022-05-04 |
| A Rollover Study to Evaluate the Long-Term Safety and Efficacy of Ocrelizumab In Patients With Multiple Sclerosis (NCT05269004) | Hoffmann-La Roche | 2022-05-03 |
| Physical Training for People With Parkinson's Disease and Multiple Sclerosis: Effect on Mind and Body (NCT05357638) | Amsterdam UMC, location VUmc | 2022-05-02 |
| The Effect of Extra Virgin Olive Oil in People With Multiple Sclerosis (NCT04787497) | University of Cyprus | 2022-05-01 |
| A Pilot Project for Multifidus Muscle Evaluation in Patients With Multiple Sclerosis (NCT05427045) | University of Arkansas | 2022-05-01 |
| Electrical Stimulations on Pain, Functional Capacity and Quality of Life in Multiple Sclerosis (NCT05110586) | Kahramanmaras Sutcu Imam University | 2022-05-01 |
| Proprioceptive Neuromuscular Facilitation in Multiple Sclerosis (NCT05342025) | Biruni University | 2022-05-01 |
| Cardiovascular Fitness of Patients With Multiple Sclerosis, Effect of Exercise on Fatigue and Depression (NCT05671588) | University Hospital Ostrava | 2022-05-01 |
| Immune Profiles in Multiple Sclerosis (MS) Patients and Healthy Volunteers Through Thoracic Duct Cannulation (NCT05162638) | University of Pennsylvania | 2022-04-19 |
| The Relationship of Neuropathic Pain With Incontinence, Disability and Life Quality in Multiple Sclerosis Patients (NCT05374811) | Istanbul University - Cerrahpasa | 2022-04-15 |
| RIS International Cohort (NCT05388331) | Centre Hospitalier Universitaire de Nice | 2022-04-15 |
| Effects of Telerehabilitation-Based Motor Imagery Training on Pain in People With Multiple Sclerosis (NCT05326711) | Dokuz Eylul University | 2022-04-11 |
| Pilates+4MS: Pilates Intervention for Multiple Sclerosis (NCT06300619) | University of Colorado, Colorado Springs | 2022-04-05 |
| The Use of Arabic Otago Exercise Program in People With Multiple Sclerosis (NCT04818008) | University of Jordan | 2022-04-01 |
| Observational Study of the Effect of Ozanimod on Fatigue in Multiple Sclerosis Patients (NCT05319093) | Brigham and Women's Hospital | 2022-04-01 |
| Study of Home Use of the Jaco Robotic Manipulation Device by Individuals With Tetraplegia (NCT07680361) | Association APPROCHE | 2022-03-30 |
| DreaMS - Validation Study 1 (NCT05009160) | Research Center for Clinical Neuroimmunology and Neuroscience Basel | 2022-03-30 |
| Safety and Efficacy of Extracorporeal Photopheresis (ECP) in the Treatment of Multiple Sclerosis (NCT05168384) | Abu Dhabi Stem Cells Center | 2022-03-26 |
| Mechanisms of Cannabidiol in Persons With MS: the Role of Sleep and Pain Phenotype (NCT05269628) | Tiffany J. Braley, MD, MS | 2022-03-25 |
| An Extension Clinical Study of the Efficacy and Safety of BCD-132 in Patients With Multiple Sclerosis Who Previously Received Therapy in Clinical Studies of JSC BIOCAD (NCT06987851) | Biocad | 2022-03-22 |
| HFS (High-Fiber Supplement) in MS (Multiple Sclerosis) (NCT04574024) | Suhayl Dhib-Jalbut, MD | 2022-03-21 |
| Pilates Training in Multiple Sclerosis (NCT04011579) | Fondazione Italiana Sclerosi Multipla | 2022-03-15 |
| Defining an Immunological Signature Related to Lesion Location in Multiple Sclerosis (NCT05326048) | Rennes University Hospital | 2022-03-09 |
| LONG-TERM EFFECTIVENESS AND SAFETY EVALUATION OF OCRELIZUMAB (NCT05210621) | Centre Hospitalier Universitaire de Nice | 2022-03-08 |
| CCMR Two: A Phase IIa, Randomised, Double-blind, Placebo-controlled Trial of the Ability of the Combination of Metformin and Clemastine to Promote Remyelination in People With Relapsing-remitting Multiple Sclerosis Already on Disease-modifying Therapy (NCT05131828) | Cambridge University Hospitals NHS Foundation Trust | 2022-03-08 |
| Laughter Yoga for Improving Sexual Function and Psychosocial Outcomes in Multiple Sclerosis (NCT06947434) | Istanbul University | 2022-03-01 |
| Exopulse Mollii Suit, Spasticity & Tissue Oxygenation (NCT05362006) | Institut De La Colonne Vertebrale Et Des Neurosciences | 2022-03-01 |
| A Pilot Nutrition Program for Spinal Cord Injury and MS (NCT03977922) | Brock University | 2022-02-28 |
| Neuroprotection With N-acetyl Cysteine for Patients With Progressive Multiple Sclerosis (NCT05122559) | Emmanuelle Waubant, MD PhD | 2022-02-16 |
| Covid-19 Vaccine Immune Response in Multiple Sclerosis (NCT05269888) | University Hospitals of North Midlands NHS Trust | 2022-02-16 |
| Ocrelizumab for Preventing Clinical Multiple Sclerosis in Individuals With Radiologically Isolated Disease. (NCT04877457) | Yale University | 2022-02-15 |
| A Self-management Program to Prevent Falls in People With Multiple Sclerosis (NCT04317716) | Karolinska Institutet | 2022-02-11 |
| Cognitive Markers in Prodromal MS (NCT05543915) | NYU Langone Health | 2022-02-09 |
| Impact of the Modifications of Environmental Exposures and Health Care Access During COVID-19 Lockdown on Multiple Sclerosis (NCT05033782) | Assistance Publique - Hôpitaux de Paris | 2022-02-08 |
| L Test in Multiple Sclerosis (NCT05325359) | Firat University | 2022-02-07 |
| Strengthening Mental Abilities With Relational Training (SMART) in Multiple Sclerosis (MS): A Feasibility Trial (NCT04975685) | University of Lincoln | 2022-02-07 |
| Effects of Pelvic Floor Strengthening and Relaxation Exercises in Women Diagnosed With Multiple Sclerosis (NCT07485556) | Gazi University | 2022-02-02 |
| Drug Repurposing Using Metformin for Improving the Therapeutic Outcome in Multiple Sclerosis Patients (NCT05298670) | German University in Cairo | 2022-02-01 |
| Designing Virtual Reality-based Software for People With Multiple Sclerosis (NCT05420532) | Yuzuncu Yil University | 2022-01-30 |
| Gut Microbiome and Depression (NCT05808101) | Washington University School of Medicine | 2022-01-27 |
| Remyelination in Multiple Sclerosis: a PET-MR Longitudinal Study Investigating Individual Profiles of Myelin Repair and the Contribution of Neuroinflammation (NCT05147532) | Assistance Publique - Hôpitaux de Paris | 2022-01-24 |
| Neuromuscular Electrostimulation in Multiple Sclerosis People With Dysphagia (NCT05063708) | I.R.C.C.S. Fondazione Santa Lucia | 2022-01-21 |
| Sensory Integration Disorders in Patients With MS Including Disease Advancement and Relapses in the Last Year (NCT05449574) | Pomeranian Medical University Szczecin | 2022-01-20 |
| Impact Program for Multiple Sclerosis (NCT05165238) | University of Alabama at Birmingham | 2022-01-10 |
| Assessment of Immune Response in Multiple Sclerosis Patients With COVID-19/Vaccination Treated With Ofatumumab and Other Disease Modifying Therapies (NCT05950308) | Novartis Pharmaceuticals | 2022-01-05 |
| Lifestyle Weight Management Program: Interviews and Stakeholder Meetings. (NCT05070286) | Oxford Brookes University | 2022-01-01 |
| Low-Load Blood Flow Restriction on Patients With Multiple Sclerosis (NCT05177952) | University of Central Florida | 2022-01-01 |
| Histaminergic Basis of Fatigue in Multiple Sclerosis (NCT04764383) | University of Miami | 2022-01-01 |
| Trunk Control and Disability in Persons With Multiple Sclerosis (NCT06327789) | Zonguldak Bulent Ecevit University | 2021-12-21 |
| Investigating the Home-based RCTs of Pilates Exercises and Cognitive Rehabilitation Exercises for Executive Functions and Anxiety in MS. (NCT05185986) | Arak University of Medical Sciences | 2021-12-20 |
| Post-Authorization Safety Study for Assessment of Pregnancy Outcomes in Patients Treated With Mayzent (NCT04933552) | Novartis Pharmaceuticals | 2021-12-15 |
| Telerehabilitation-based Upper Extremity Training in People With Multiple Sclerosis (NCT05073731) | Dokuz Eylul University | 2021-12-15 |
| China National Registry of Neuro-Inflammatory Diseases (NCT05154370) | Beijing Tiantan Hospital | 2021-12-15 |
| Artificial Intelligence in Predicting Progression in Multiple Sclerosis Study (NCT05426980) | University of Ljubljana | 2021-12-13 |
| Quest to Analyze One Thousand Humans Meditating (NCT06583395) | Tobias Moeller-Bertram | 2021-12-05 |
| Survey Among Healthcare Professionals and MS Patients to Assess Their Understanding of RMP Materials (NCT05301907) | Novartis Pharmaceuticals | 2021-12-02 |
| Arm Swing During Walking in Early Multiple Sclerosis (NCT05821257) | Istanbul University - Cerrahpasa | 2021-12-01 |